Metaproterenol Sulfate Tablets Rx
Generic Name and Formulations:
Metaproterenol sulfate 10mg, 20mg.
Various generic manufacturers
Indications for Metaproterenol Sulfate Tablets:
20mg 3–4 times daily.
<6yrs: not recommended. 6–9yrs (<60 lbs): 10mg 3–4 times daily. >9yrs (>60 lbs): 20mg 3–4 times daily.
Arrhythmias associated with tachycardia.
Avoid excessive use. Hypertension. Cardiovascular disease. CHF. Hyperthyroidism. Diabetes. Seizure disorders. Pregnancy (Cat.C). Nursing mothers.
Avoid other aerosol β-agonists. Potentiated by sympathomimetics, tricyclics, MAOIs.
Tachycardia, nervousness, tremor, headache, dizziness, GI upset, hypertension, paradoxical bronchospasm, cough, bad taste.
Inh soln, tabs, syrup—contact supplier.
Clinical Pain Advisor Articles
- Chronic Neuropathic Pain Updated Classification by IASP for ICD-11
- Buprenorphine-Naloxone Found to Be More Cost-Effective Than Extended-Release Naltrexone
- Ultrasound-Guided C2 Coblation May Be Effective for Cervicogenic Headache
- Meta-Analysis of Opioid Treatment for Chronic Noncancer Pain
- Opioids Found to Increase Risk for Community-Acquired Pneumonia, Particularly in HIV
- Reviewing the Use of Buprenorphine in Perioperative Pain Management
- Early Physical Therapy for Musculoskeletal Pain May Reduce Opioid Use
- External Trigeminal Nerve Stimulation May Alleviate Migraine Pain
- IASP Updates Diagnosis Criteria for Chronic Primary Pain for ICD-11
- Galcanezumab Provides Persistent Preventive Effects in Episodic, Chronic Migraine
- Comparable Analgesia With Low-Dose IV Ketamine, Morphine for Acute Pain
- Benzodiazepines, if Prescribed, May Not Affect Methadone Treatment Retention
- When Opioid Prescribing Guidelines Become Rules
- IV Fluid Confers No Significant Treatment Effect on Migraine Pain
- American Headache Society Releases Position Statement on Novel Preventive and Acute Migraine Treatments